Previous 10 | Next 10 |
2023-11-19 12:00:00 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Perfectly Priced Healthcare Giant Novo Nordisk A/S (NVO) Novo Nordisk R&D Investor Event (Transcript) Eli Lilly: Favorable Developments Continue Regarding Anti-Obesity Drug Franchise ...
Boston Scientific Closes Acquisition of Relievant Medsystems, Inc. PR Newswire Recent healthcare plan coverage of Intracept ® system expands access to vertebrogenic pain treatment for tens of millions of patients MARLBOROUGH, Mass. , Nov. 17, 202...
by Drew Bomett, VP & Chief Information Security Officer, Boston Scientific NORTHAMPTON, MA / ACCESSWIRE / November 14, 2023 / Boston Scientific Originally published by Drew Bomett on The MedTech Conference . Increasingly, hospital systems today find themselves targeted by cybercrimina...
2023-11-13 12:13:48 ET More on DexCom, Novo, etc. Novo Nordisk A/S (NVO) Novo Nordisk R&D Investor Event (Transcript) Eli Lilly: Favorable Developments Continue Regarding Anti-Obesity Drug Franchise Eli Lilly and Company (LLY) Presents at UBS Biopharma 2023 Confe...
2023-11-12 01:45:00 ET Summary Eccogene out-licenses global rights for its GLP-1 agonist to AstraZeneca in a $2 billion deal. Biotheus sells ex-China rights for a bispecific antibody candidate to BioNTech for $55 million upfront. WuXi XDC conducts a $500 million Hong Kong IPO ...
NORTHAMPTON, MA / ACCESSWIRE / November 7, 2023 / Boston Scientific Originally published by DeviceTalks In this episode of Boston Scientific Talks, Sandra Nagale, PhD, Director of Digital Health Platforms and Products, breaks down the transformative role of AI within the medical device indust...
2023-11-02 11:35:06 ET Summary GE HealthCare's revenue growth is expected to benefit from healthy order bookings and backlog levels, along with easing supply chain challenges. The company's revenues should also benefit from volume growth fueled by good end-market demand and strong...
Boston Scientific to Participate in Stifel's 2023 Healthcare Conference PR Newswire MARLBOROUGH, Mass. , Nov. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Stifel's 2023 Healthcare Conference on Tuesday, November 14, 2023...
NORTHAMPTON, MA / ACCESSWIRE / October 31, 2023 / Boston Scientific / Cynthia doesn't even want to think about what could've happened if she didn't go in for that check-up. It was 2020, and Cynthia was at an appointment with the orthopedic surgeon who was scheduled to perform a disc replacement...
2023-10-30 18:01:49 ET Summary Boston Scientific Corporation delivered strong third quarter results, including double-digit organic revenue growth, but the results weren't much better than the Street already expected. The recent clinical data on the Agent DCB and the acquisition o...
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Boston Scientific Announces Results for Second Quarter 2024 PR Newswire MARLBOROUGH, Mass. , July 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.120 billion during the second quarter of 2024, growing 14.5 percent ...
Shares of Boston Scientific Corporation (NYSE: BSX) traded at a new 52-week high today and are currently trading at $78.31. So far today, approximately 1.5M shares have been exchanged, as compared to an average 30-day volume of 5.37M shares. Boston Scientific Corporation develops, manufacture...